Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenues:    
Total revenues $ 48,450,900 $ 36,661,660
Cost of revenues:    
Total cost of revenues 5,565,917 4,310,249
Selling and marketing expenses 6,913,709 4,819,555
Depreciation and amortization 1,899,257 1,556,240
General and administrative expenses 30,543,030 25,238,121
Total selling, general and administrative expenses 39,355,996 31,613,916
Net loss on disposition or impairment 114,352 594,934
Income from operations 3,414,635 142,561
Other income (expense):    
Bargain purchase gain 19,298 13,198
Other (expense), net (61,515) (46,791)
Total other (expense) (42,217) (33,593)
Income before income tax expense (benefit) 3,372,418 108,968
Income tax expense (benefit) 48,706 (37,728)
Net income and comprehensive income 3,323,712 146,696
Less: income attributable to the non-controlling interest 0 0
Net income attributable to The Joint Corp. stockholders $ 3,323,712 $ 146,696
Earnings per share:    
Basic earnings per share (in dollars per share) $ 0.24 $ 0.01
Diluted earnings per share (in dollars per share) $ 0.23 $ 0.01
Basic weighted average shares (in shares) 13,819,149 13,669,107
Diluted weighted average shares (in shares) 14,467,567 14,031,717
Revenues from company-owned or managed clinics    
Revenues:    
Total revenues $ 25,807,584 $ 19,545,276
Royalty fees    
Revenues:    
Total revenues 13,557,170 10,141,036
Franchise    
Revenues:    
Total revenues 1,791,545 1,688,039
Cost of revenues:    
Cost of revenues 5,159,778 3,956,530
Advertising fund revenue    
Revenues:    
Total revenues 3,884,055 2,862,244
Software/IT    
Revenues:    
Total revenues 1,865,779 1,290,135
Cost of revenues:    
Cost of revenues 406,139 353,719
Regional developer fees    
Revenues:    
Total revenues 803,849 599,370
Other revenues    
Revenues:    
Total revenues $ 740,918 $ 535,560